Emily Pond

Researchers compared the efficacy of intravenous cyclophosphamide and other immunosuppressants in the treatment of idiopathic inflammatory myopathy-related interstitial lung disease.

The incidence rates of infection, cardiovascular events, and malignancies were compared between JAK vs TNF inhibitors use among patients with RA.

Researchers evaluated the validity and usability of a new electronic patient-reported outcome measure for Raynaud phenomenon among patients with systemic sclerosis.

The researchers evaluated the clinical characteristics of uveitis in patients with psoriatic arthritis, as well as the effect of uveitis on health-related quality of life.

Consensus recommendations were developed, based on expert physician insights, for the management of systemic sclerosis-associated interstitial lung disease.

Researchers studied the factors associated with quality care among patients with rheumatoid arthritis.

Researchers assessed whether CA72-4 is a predictor for gout flares during initiation with urate-lowering therapy.

Researchers of a systematic review studied the efficacy of bDMARDs and tsDMARDs to inform the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.

Researchers studied the effect of ixekizumab retreatment at 104 weeks after withdrawal of therapy on risk for flares in patients with axial spondyloarthritis.

The incidence and clinical and serologic characteristics of anti-TNF-induced lupus in patients with inflammatory bowel disease receiving TNF inhibitors were assessed.

Researchers compared the diagnostic performance of 3 classification criteria – ACR-1997, SLICC-2012, and EULAR/ACR-2019 – for systemic lupus erythematosus.

Researchers assessed the prevalence of prolonged COVID-19 symptom duration among patients with systemic autoimmune rheumatic diseases.

Researchers used data from the ACR RISE registry to evaluate a treat-to-target approach among patients with gout receiving urate-lowering therapy.

The epidemiology of psoriatic arthritis (PsA) and means of PsA treatment and prevention in patients with psoriasis are outlined.

Researchers assessed whether tumor necrosis factor inhibitor use affected birth outcomes in patients with rheumatoid arthritis.

Researchers sought to evaluate the impact of risankizumab vs placebo on health care-related quality of life and other patient-reported outcomes in patients with psoriatic arthritis.

This study looked at whether a clinician training program for enhancing patient-counselor communication about sexual risk behavior in those with substance use disorder was effective.

Researchers examined whether weight loss improves rheumatoid arthritis activity and/or musculoskeletal synovitis measures in patients with obesity.

Researchers assessed the benefit and harm of widely-used, low-dose glucocorticoid therapy in older adults with rheumatoid arthritis.

Researchers evaluated the differences in treatment response to ixekizumab between men and women with psoriatic arthritis.

Researchers investigated the potential role in ultrasonography in the detection of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA).

Cox proportional hazard models were used to assess the relative risk for substance use disorder among patients with and without prior suicide attempt.

Researchers investigated the seroreactivity of COVID-19 vaccination and adverse events among patients with systemic lupus erythematosus and rheumatoid arthritis.

Researchers explored the association between rheumatoid arthritis and cardiovascular disease among US adults aged 20 years and older.

Researchers assessed the effects of FDA-approved OTC and prescription laxatives for chronic constipation in pregnant patients.

Researchers sought to determine the outcomes among pediatric patients with rheumatic disease and COVID-19.

Researchers studied the link between clinical examination and ultrasound synovitis in DMARD-naive patients with early psoriatic arthritis.

Researchers assessed the frequency and determinants of flares in patients with systemic lupus erythematosus, as well as studied the effects of glucocorticoid tapering on flares in patients who achieved low disease activity or remission.

Survivors of critical illness are at greater risk for psychiatric disorders. Current clinical guidelines advocate for family visitation in the ICU, which can provide emotional support and assistance in decision making. However, the precise impact of family visitation on post-ICU psychiatric risk remains unclear.

Study authors described antibody responses among patients with rheumatic and musculoskeletal diseases receiving immunosuppressant therapy 6 months after completing the COVID-19 vaccine series.